PMC:7373848 / 27262-27503 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T477","span":{"begin":4,"end":15},"obj":"Body_part"},{"id":"T478","span":{"begin":74,"end":77},"obj":"Body_part"},{"id":"T479","span":{"begin":109,"end":116},"obj":"Body_part"}],"attributes":[{"id":"A477","pred":"fma_id","subj":"T477","obj":"http://purl.org/sig/ont/fma/fma63194"},{"id":"A478","pred":"fma_id","subj":"T478","obj":"http://purl.org/sig/ont/fma/fma62874"},{"id":"A479","pred":"fma_id","subj":"T479","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"ing capillaries and microhemorrhages. In children with chilblain lesions, IgA antibodies to SARS–CoV-2 spike protein S1 domain are observed, suggesting that their immune response represents mucosal protection that lessens the likelihood of t"}

{"project":"LitCovid-PubTator","denotations":[{"id":"508","span":{"begin":103,"end":108},"obj":"Gene"},{"id":"510","span":{"begin":41,"end":49},"obj":"Species"},{"id":"511","span":{"begin":92,"end":102},"obj":"Species"},{"id":"514","span":{"begin":20,"end":36},"obj":"Disease"}],"attributes":[{"id":"A508","pred":"tao:has_database_id","subj":"508","obj":"Gene:43740568"},{"id":"A510","pred":"tao:has_database_id","subj":"510","obj":"Tax:9606"},{"id":"A511","pred":"tao:has_database_id","subj":"511","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ing capillaries and microhemorrhages. In children with chilblain lesions, IgA antibodies to SARS–CoV-2 spike protein S1 domain are observed, suggesting that their immune response represents mucosal protection that lessens the likelihood of t"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T126","span":{"begin":92,"end":96},"obj":"Disease"}],"attributes":[{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ing capillaries and microhemorrhages. In children with chilblain lesions, IgA antibodies to SARS–CoV-2 spike protein S1 domain are observed, suggesting that their immune response represents mucosal protection that lessens the likelihood of t"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T468","span":{"begin":117,"end":119},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"}],"text":"ing capillaries and microhemorrhages. In children with chilblain lesions, IgA antibodies to SARS–CoV-2 spike protein S1 domain are observed, suggesting that their immune response represents mucosal protection that lessens the likelihood of t"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T186","span":{"begin":109,"end":116},"obj":"Chemical"}],"attributes":[{"id":"A186","pred":"chebi_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"ing capillaries and microhemorrhages. In children with chilblain lesions, IgA antibodies to SARS–CoV-2 spike protein S1 domain are observed, suggesting that their immune response represents mucosal protection that lessens the likelihood of t"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T52","span":{"begin":55,"end":72},"obj":"Phenotype"}],"attributes":[{"id":"A52","pred":"hp_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/HP_0009710"}],"text":"ing capillaries and microhemorrhages. In children with chilblain lesions, IgA antibodies to SARS–CoV-2 spike protein S1 domain are observed, suggesting that their immune response represents mucosal protection that lessens the likelihood of t"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T111","span":{"begin":163,"end":178},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ing capillaries and microhemorrhages. In children with chilblain lesions, IgA antibodies to SARS–CoV-2 spike protein S1 domain are observed, suggesting that their immune response represents mucosal protection that lessens the likelihood of t"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T870","span":{"begin":4,"end":15},"obj":"UBERON:0001982"},{"id":"T871","span":{"begin":74,"end":88},"obj":"GO:0071743"},{"id":"T872","span":{"begin":92,"end":102},"obj":"SP_7"},{"id":"T873","span":{"begin":120,"end":126},"obj":"SO:0000417"},{"id":"T874","span":{"begin":163,"end":169},"obj":"UBERON:0002405;GO:0006955"},{"id":"T875","span":{"begin":170,"end":178},"obj":"GO:0006955"},{"id":"T876","span":{"begin":190,"end":197},"obj":"UBERON:0000912"}],"text":"ing capillaries and microhemorrhages. In children with chilblain lesions, IgA antibodies to SARS–CoV-2 spike protein S1 domain are observed, suggesting that their immune response represents mucosal protection that lessens the likelihood of t"}